Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Pe’er, D. Shweiki, A. Itin, I. Hemo, H. Gnessin, E. Keshet (1995)
Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.Laboratory investigation; a journal of technical methods and pathology, 72 6
J. Wells, R. Murthy, R. Chibber, Alistair Nunn, P. Molinatti, E. Kohner, Z. Gregor (1996)
Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation.British Journal of Ophthalmology, 80
H. Sone, Y. Kawakami, Y. Okuda, S. Kondo, Hanatani Mitsuya, Hideo Suzuki, Kamejiro Yamashita (1996)
Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells.Biochemical and biophysical research communications, 221 1
F. Malecaze, S. Clamens, V. Simorre-Pinatel, A. Mathis, P. Chollet, C. Favard, F. Bayard, J. Plouët (1994)
Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy.Archives of ophthalmology, 112 11
P. Adamis, J. Miller, M. Bernal, D. DʼAmico, J. Folkman, T. Yeo, K. Yeo (1995)
Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic RetinopathyRetina-the Journal of Retinal and Vitreous Diseases, 15
L. Dirix, P. Vermeulen, G. Hubens, I. Benoy, M. Martín, C. Pooter, A. Oosterom (1996)
Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 7 8
Lloyd Aiello, Robert Avery, P. Arrigg, Bruce Keyt, H. Jampel, Sabera Shah, Louis Pasquale, Hagen Thieme, Mami Iwamoto, John Park (1994)
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.The New England journal of medicine, 331 22
W. Roberts, G. Palade (1995)
Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.Journal of cell science, 108 ( Pt 6)
T. Murata, K. Nakagawa, A. Khalil, T. Ishibashi, H. Inomata, K. Sueishi (1996)
The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.Laboratory investigation; a journal of technical methods and pathology, 74 4
P. Baker, J. Krasnow, J. Roberts, K. Yeo (1995)
Elevated Serum Levels of Vascular Endothelial Growth Factor in Patients With PreeclampsiaObstetrics & Gynecology, 86
Vascular endothelial growth factor (VEGF) plays a major role in the development of neovascularization in proliferative diabetic retinopathy (PDR). The source of intravitreous VEGF is presumably ischaemic retina, but increased levels derived from serum cannot be excluded. The aim of the study is to determine the intravitreous concentrations of VEGF in diabetic patients with PDR and to investigate whether serum VEGF could contribute to the intravitreous concentration. For this purpose, we studied 20 diabetic patients (5 IDDM and 15 NIDDM) with PDR in whom a vitrectomy was performed (group A). Non-diabetic patients ( n = 13) with other conditions requiring vitrectomy served as a control group (group B). In both groups, VEGF was determined in serum and undiluted vitreous samples obtained simultaneously. Furthermore, serum VEGF was determined in 69 healthy control subjects (group C) and 39 diabetic patients without microvascular complications (group D). Vitreous and serum VEGF was determined by ELISA (R & D Systems, Abingdon, UK); intra-assay CV 3.8 %, interassay CV 5.1 %. Intravitreous concentrations of VEGF were strikingly higher in group A (median 1.75 ng/ml, range 0.33–6.66) in comparison with group B (median 0.009 ng/ml, range 0.009–0.038); p < 0.0001. This difference remained significant after adjusting for intravitreous protein concentration ( p < 0.05). Differences in serum VEGF among the groups included in the study were not found. We conclude that the high vitreous levels of VEGF observed in diabetic patients with PDR cannot be attributed to serum diffusion across the blood-retinal barrier. Therefore, intraocular synthesis is the main contributing factor for the high vitreous VEGF concentrations observed in PDR. (Diabetologia (1997) 40: 1107–1109)
Diabetologia – Springer Journals
Published: Aug 1, 1997
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.